FOXC1 and acute myeloid leukemia: More widely, high-level FOXC1 expression is also observed in a multitude of solid malignancies, including breast, colorectal, cervical, gastric, and liver cancers (Gilding and Somervaille, 2019), where functional experiments confirm that it promotes increased migration and metastasis and, as in AML, typically confers an inferior survival.